Atorvastatin Calcium Tablet
Product Images NDC 50090-5634

5 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-5634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (D800d38e 825d 41d4 B833 0e693d0851e0 01)

Image-01 (D800d38e 825d 41d4 B833 0e693d0851e0 01)
Chemical structure diagram of Atorvastatin Calcium showing its molecular arrangement including calcium and water of hydration components (Ca2+ and 3H2O). The structure indicates two molecules of the atorvastatin ion complexed with calcium.*
FDA Label Image

Figure 1: Effect Of Atorvastatin Calcium 10 mg/day On Cumulative Incidence Of Non-fatalmyocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (D800d38e 825d 41d4 B833 0e693d0851e0 02)

Figure 1: Effect Of Atorvastatin Calcium 10 mg/day On Cumulative Incidence Of Non-fatalmyocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (D800d38e 825d 41d4 B833 0e693d0851e0 02)
A line graph showing cumulative incidence (%) over 3.5 years, comparing Atorvastatin with placebo. The solid line represents Atorvastatin and the dashed line represents placebo. The graph includes a hazard ratio (HR) of 0.64 with confidence interval 0.50-0.83 and a p-value of 0.0005.*
FDA Label Image

Figure 2: Effect Of Atorvastatin Calcium 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization, Or Stroke) (D800d38e 825d 41d4 B833 0e693d0851e0 03)

Figure 2: Effect Of Atorvastatin Calcium 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization, Or Stroke) (D800d38e 825d 41d4 B833 0e693d0851e0 03)
A line chart comparing the cumulative hazard percentage over time (up to 5 years) between Atorvastatin and placebo groups. The X-axis represents time to first primary endpoint through four years of follow-up, and the Y-axis shows cumulative hazard percentage. The graph shows a lower cumulative hazard for Atorvastatin compared to placebo with hazard ratio (HR) 0.63 (0.48-0.83) and p=0.001.*
FDA Label Image

Figure 3: Effect Of Atorvastatin Calcium 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (D800d38e 825d 41d4 B833 0e693d0851e0 04)

Figure 3: Effect Of Atorvastatin Calcium 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (D800d38e 825d 41d4 B833 0e693d0851e0 04)
A line graph comparing the percentage of subjects experiencing a first major cardiovascular event over five years for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes hazard ratio (HR 0.78) with confidence intervals and a p-value.*
FDA Label Image

Label Image (Lbl500905634)

Label Image (Lbl500905634)
The label for Atorvastatin Calcium 20 mg tablets by A-S Medication Solutions. It specifies the oral film-coated tablets containing atorvastatin calcium equivalent to 20 mg atorvastatin. The package contains 30 tablets, with storage instructions at 77 degrees Fahrenheit. Label includes product and lot numbers, a barcode, and packaging location in Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.